Scrip Regulatory Affairs
European Commission go-ahead to GMDN opens door for Eudamed
09 February 2010
Amanda Maxwell
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Australian Senate panel inquiry expresses shock at patient experiences with DePuy hip devices; calls for stricter regulations
- Canada consults on use of foreign review reports in evaluation of drugs, devices
- Moves to incorporate GMDN into SNOMED under way for better patient records and info on devices
- Australian medtech stakeholders call for regulatory improvements in Govt inquiry
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
